Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.
Dickson R, Bagust A, Boland A, Blundell M, Davis H, Dundar Y, Hockenhull J, Martin Saborido C, Oyee J, Ramani VS. Dickson R, et al. Among authors: hockenhull j. Pharmacoeconomics. 2011 Dec;29(12):1051-62. doi: 10.2165/11591600-000000000-00000. Pharmacoeconomics. 2011. PMID: 21967156 Clinical Trial.
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Hockenhull J, Proudlove C, Dundar Y, Richardson M, Dickson R, Mullard A, Marshall E. Greenhalgh J, et al. Among authors: hockenhull j. Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470. Health Technol Assess. 2015. PMID: 26134145 Free PMC article. Review.
Rituximab for the treatment of rheumatoid arthritis.
Bagust A, Boland A, Hockenhull J, Fleeman N, Greenhalgh J, Dundar Y, Proudlove C, Kennedy T, Moots R, Williamson P, Dickson R. Bagust A, et al. Among authors: hockenhull j. Health Technol Assess. 2009 Sep;13 Suppl 2:23-9. doi: 10.3310/hta13suppl2/04. Health Technol Assess. 2009. PMID: 19804686 Free article. Review.
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Greenhalgh J, et al. Among authors: hockenhull j. Cochrane Database Syst Rev. 2010 May 12;(5):CD004587. doi: 10.1002/14651858.CD004587.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2015 Oct 20;(10):CD004587. doi: 10.1002/14651858.CD004587.pub3 PMID: 20464732 Updated. Review.
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Nicholson A, Mahon J, Boland A, Beale S, Dwan K, Fleeman N, Hockenhull J, Dundar Y. Nicholson A, et al. Among authors: hockenhull j. Health Technol Assess. 2015 Oct;19(87):i-xxxi, 1-191. doi: 10.3310/hta19870. Health Technol Assess. 2015. PMID: 26507078 Free PMC article. Review.
Erlotinib for the treatment of relapsed non-small cell lung cancer.
McLeod C, Bagust A, Boland A, Hockenhull J, Dundar Y, Proudlove C, Davis H, Green J, Macbeth F, Stevenson J, Walley T, Dickson R. McLeod C, et al. Among authors: hockenhull j. Health Technol Assess. 2009 Jun;13 Suppl 1:41-7. doi: 10.3310/hta13suppl1/07. Health Technol Assess. 2009. PMID: 19567213 Free article.
59 results